Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genomics02:02

Genomics

36.2K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
36.2K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

64
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
64
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

103
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
103
Multi-input and Multi-variable systems01:22

Multi-input and Multi-variable systems

103
Cruise control systems in cars are designed as multi-input systems to maintain a driver's desired speed while compensating for external disturbances such as changes in terrain. The block diagram for a cruise control system typically includes two main inputs: the desired speed set by the driver and any external disturbances, such as the incline of the road. By adjusting the engine throttle, the system maintains the vehicle's speed as close to the desired value as possible.
In the absence...
103
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

51
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
51

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical subphenotypes in septic patients with new-onset atrial fibrillation: validation and parsimonious classifier model development.

BMC medical informatics and decision making·2026
Same author

Sex-specific modulation of gut microbiota by empagliflozin contributes to renoprotection in diabetic kidney disease mice.

Frontiers in microbiology·2026
Same author

BioMedGraphica: an all-in-one platform for joint textual biomedical prior knowledge and numeric graph generation.

Bioinformatics (Oxford, England)·2026
Same author

Study on the influence of steel reinforcement on the bonding performance and crack width of UHPC-NSC interface.

Scientific reports·2026
Same author

IVUS-optimized sequential rotational atherectomy with IABP support for severely calcified unprotected left main disease: a systematic integration strategy: a case report.

European heart journal. Case reports·2026
Same author

Interpreting Omics Data Analysis with Large Language Models for Disease Target and Drug Discovery.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jun 13, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.2K

M3NetFlow: A novel multi-scale multi-hop graph AI model for integrative multi-omic data analysis.

Heming Zhang1, S Peter Goedegebuure2,3, Li Ding3,4

  • 1Institute for Informatics, Data Science and Biostatistics (I2DB), Washington University School of Medicine, St. Louis, MO, USA.

Biorxiv : the Preprint Server for Biology
|September 16, 2024
PubMed
Summary

This study introduces M3NetFlow, a novel graph model for analyzing complex multi-omic data. It accurately ranks potential drug targets and identifies key disease signaling pathways, advancing precision medicine.

More Related Videos

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

983
Author Spotlight: Integrating Organoid Models with Single-Cell and Spatial Transcriptomics Technologies
05:45

Author Spotlight: Integrating Organoid Models with Single-Cell and Spatial Transcriptomics Technologies

Published on: March 29, 2024

2.2K

Related Experiment Videos

Last Updated: Jun 13, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.2K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

983
Author Spotlight: Integrating Organoid Models with Single-Cell and Spatial Transcriptomics Technologies
05:45

Author Spotlight: Integrating Organoid Models with Single-Cell and Spatial Transcriptomics Technologies

Published on: March 29, 2024

2.2K

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Systems Biology

Background:

  • Multi-omic data integration is crucial for precision medicine but challenging due to high dimensionality and complex interactions.
  • Identifying molecular targets and core signaling pathways in complex diseases requires advanced analytical approaches.

Purpose of the Study:

  • To develop a novel computational model, M3NetFlow, for generic multi-omic data analysis.
  • To enable accurate target ranking and inference of core signaling pathways from multi-omic datasets.
  • To address the challenge of interpreting complex interactions within multi-omic data.

Main Methods:

  • Proposed a novel Multi-scale Multi-hop Multi-omic graph model named M3NetFlow.
  • Applied M3NetFlow to two independent multi-omic case studies: synergistic drug combination response and Alzheimer's disease.
  • Evaluated model performance based on prediction accuracy and interpretability of identified targets and pathways.

Main Results:

  • M3NetFlow demonstrated superior prediction accuracy compared to existing methods.
  • The model successfully identified essential molecular targets and core signaling pathways in both case studies.
  • Results highlight the model's capability for anchor-target guided learning and biomarker discovery.

Conclusions:

  • M3NetFlow provides an effective framework for multi-omic data analysis, target ranking, and pathway inference.
  • The model enhances understanding of complex disease mechanisms and supports precision healthcare initiatives.
  • M3NetFlow is a versatile tool applicable to diverse multi-omic studies and is publicly available.